ATE237614T1 - Benzo(c)chinolizin derivate,deren herstellung und verwendung als 5-alfa-reduktase inhibitoren - Google Patents

Benzo(c)chinolizin derivate,deren herstellung und verwendung als 5-alfa-reduktase inhibitoren

Info

Publication number
ATE237614T1
ATE237614T1 AT97903230T AT97903230T ATE237614T1 AT E237614 T1 ATE237614 T1 AT E237614T1 AT 97903230 T AT97903230 T AT 97903230T AT 97903230 T AT97903230 T AT 97903230T AT E237614 T1 ATE237614 T1 AT E237614T1
Authority
AT
Austria
Prior art keywords
benzo
preparation
derivatives
quinolicine
alfa
Prior art date
Application number
AT97903230T
Other languages
English (en)
Inventor
Antonio Guarna
Mario Serio
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of ATE237614T1 publication Critical patent/ATE237614T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • C07D455/06—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine containing benzo [a] quinolizine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT97903230T 1996-02-09 1997-02-07 Benzo(c)chinolizin derivate,deren herstellung und verwendung als 5-alfa-reduktase inhibitoren ATE237614T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96FI000019A IT1286545B1 (it) 1996-02-09 1996-02-09 Derivati benzo(c) chinolizinici,loro preparazione ed uso come inibitori delle 5-alfa-riduttasi
PCT/EP1997/000552 WO1997029107A1 (en) 1996-02-09 1997-02-07 BENZO[C]QUINOLIZINE DERIVATIVES, THEIR PREPARATION AND USE AS 5α-REDUCTASES INHIBITORS

Publications (1)

Publication Number Publication Date
ATE237614T1 true ATE237614T1 (de) 2003-05-15

Family

ID=11351478

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97903230T ATE237614T1 (de) 1996-02-09 1997-02-07 Benzo(c)chinolizin derivate,deren herstellung und verwendung als 5-alfa-reduktase inhibitoren

Country Status (25)

Country Link
US (3) US6303622B1 (de)
EP (1) EP0880520B1 (de)
JP (1) JP2000504680A (de)
KR (1) KR100480448B1 (de)
CN (1) CN1116296C (de)
AT (1) ATE237614T1 (de)
AU (1) AU711886C (de)
BG (1) BG64596B1 (de)
CZ (1) CZ298061B6 (de)
DE (1) DE69720966T2 (de)
DK (1) DK0880520T3 (de)
EA (1) EA000975B1 (de)
EE (1) EE04058B1 (de)
ES (1) ES2192263T3 (de)
HU (1) HUP9900509A3 (de)
IL (2) IL125628A0 (de)
IT (1) IT1286545B1 (de)
MX (1) MX9806229A (de)
NO (2) NO320155B1 (de)
NZ (1) NZ331256A (de)
PL (1) PL187618B1 (de)
PT (1) PT880520E (de)
SK (1) SK283299B6 (de)
UA (1) UA67724C2 (de)
WO (1) WO1997029107A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITFI970193A1 (it) * 1997-08-01 1999-02-01 Applied Research Systems Uso di derivati benzo(c) chinolizinici come regolatori della crescita delle piante e composizioni ad uso agricolo che contengono tali
EP0926148A1 (de) * 1997-12-23 1999-06-30 Applied Research Systems Ars Holding N.V. Benzo (c)quinolizine-derivate,deren herstellung und verwendung als 5-alpha-reduktase-hemmer
US6723850B1 (en) * 1998-08-03 2004-04-20 Applied Research Systems Ars Holding N.V. Process for the synthesis of (1-H)-benzo[c]quinolizin-3-ones derivatives
AP2007004244A0 (en) 2005-05-10 2007-12-31 Intermune Inc Method of modulating stress-activated protein kinase system
JP5463034B2 (ja) * 2005-05-20 2014-04-09 アラントス・フアーマシユーテイカルズ・ホールデイング・インコーポレイテツド ピリミジン若しくはトリアジン縮合二環式メタロプロテアーゼ阻害薬
US20070155738A1 (en) 2005-05-20 2007-07-05 Alantos Pharmaceuticals, Inc. Heterobicyclic metalloprotease inhibitors
EP2296653B1 (de) 2008-06-03 2016-01-27 Intermune, Inc. Verbindungen und verfahren zur behandlung von entzündungserkrankungen und fibrotischen erkrankungen
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
RU2692485C2 (ru) 2014-04-02 2019-06-25 Интермьюн, Инк. Противофиброзные пиридиноны
CN105001216B (zh) * 2015-07-08 2017-03-01 中国科学院兰州化学物理研究所 一种喹嗪酮的制备方法
CN107089980B (zh) * 2017-05-11 2019-08-30 合肥工业大学 一种手性苯并[a]喹嗪-2-酮类化合物及其不对称催化合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3455929A (en) * 1966-08-15 1969-07-15 Bristol Myers Co Esters of 1,4-dihydroquinoline-n-carboxylic acids and thione acids
FR1534278A (fr) * 1966-08-15 1968-07-26 Bristol Myers Co Procédé de fabrication de 1, 4-dihydroquinoléine-n-carboxylates d'alcoyle
US3625877A (en) * 1968-01-08 1971-12-07 Eastman Kodak Co High-modulus polycarbonate compositions
SU1027166A1 (ru) 1981-09-11 1983-07-07 Киевский Ордена Ленина Государственный Университет Им.Т.Г.Шевченко Способ получени 1,2-полиметиленкетоцианоазагетероциклов
IE57014B1 (en) 1983-03-25 1992-03-11 Wyeth John & Brother Ltd Benzoquinolizines

Also Published As

Publication number Publication date
CN1116296C (zh) 2003-07-30
US6303622B1 (en) 2001-10-16
EE04058B1 (et) 2003-06-16
EP0880520A1 (de) 1998-12-02
AU711886C (en) 2002-10-17
CZ298061B6 (cs) 2007-06-06
US20010047098A1 (en) 2001-11-29
CZ228998A3 (cs) 1998-10-14
HUP9900509A2 (hu) 1999-06-28
PL187618B1 (pl) 2004-08-31
EE9800233A (et) 1998-12-15
ES2192263T3 (es) 2003-10-01
NO983444D0 (no) 1998-07-24
SK283299B6 (sk) 2003-05-02
EA000975B1 (ru) 2000-08-28
JP2000504680A (ja) 2000-04-18
ITFI960019A0 (de) 1996-02-09
ITFI960019A1 (it) 1997-08-09
KR19990082126A (ko) 1999-11-15
KR100480448B1 (ko) 2005-08-31
DE69720966T2 (de) 2004-05-19
IT1286545B1 (it) 1998-07-15
BG64596B1 (bg) 2005-08-31
EP0880520B1 (de) 2003-04-16
UA67724C2 (en) 2004-07-15
US6555549B2 (en) 2003-04-29
MX9806229A (es) 1998-11-30
EA199800701A1 (ru) 1999-02-25
BG102661A (en) 1999-04-30
US6552034B2 (en) 2003-04-22
NO320155B1 (no) 2005-11-07
WO1997029107A1 (en) 1997-08-14
NO20045132L (no) 1998-07-24
HK1018783A1 (en) 2000-01-07
US20010044542A1 (en) 2001-11-22
NO983444L (no) 1998-07-24
PT880520E (pt) 2003-07-31
DK0880520T3 (da) 2003-08-11
IL125628A0 (en) 1999-04-11
AU1767297A (en) 1997-08-28
HUP9900509A3 (en) 1999-11-29
PL328123A1 (en) 1999-01-18
SK104498A3 (en) 1998-12-02
DE69720966D1 (de) 2003-05-22
CN1210536A (zh) 1999-03-10
NZ331256A (en) 1999-06-29
AU711886B2 (en) 1999-10-21
IL125628A (en) 2006-10-31

Similar Documents

Publication Publication Date Title
ATE253545T1 (de) Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren
BR9916980A (pt) Derivados bicìclicos substituìdos úteis como agentes anticancerìgenos
SE9904508D0 (sv) New compounds
BR0005633A (pt) Derivados de quinolina úteis para inibição da farnesil proteìna transferase
BG103417A (en) Condensed pyrimidine bicyclic derivatives
ATE232520T1 (de) Imidazolidin-4-on derivate verwendbar als antikrebsmittel
TR199802060T2 (xx) Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�.
FI951858A0 (fi) Kinoloni- ja akridonijohdannaisia virtsanpidätyskyvyttömyyden hoidossa
TR199900732T2 (xx) PDE IV inhibe eden 2-siyanoiminoimidazol t�revleri.
ATE202342T1 (de) 5-(4-subst.-piperidinyl-1)-3-aryl-pentansäure derivate als tachykinin rezeptor antagonisten
DE69720966D1 (de) Benzo[c]chinolizin derivate,deren herstellung und verwendung als 5-alfa-reduktase inhibitoren
TR200000153T2 (tr) İl-5 inhibite eden 6-azaurasil türevleri.
IT1256320B (it) Derivati eterociclici
DE69819539D1 (de) Antithrombotische mittel
DE69330601D1 (de) Serotoninergische ergolin derivate
ATE241624T1 (de) Benzo(f)naphthyridinderivate, ihre herstellung und sie enthaltende pharmazeutische zusammenstzungen
AP9801235A0 (en) Erythromycin derivatives.
AP9901559A0 (en) Tricyclic 3-keto derivatives of 6-0-methylerythromycin.
DE69914563D1 (de) Azaindol derivate und ihre Verwendung als antithrombotische Wirkstoffe
CA2245758A1 (en) Benzo[c]quinolizine derivatives, their preparation and use as 5.alpha.-reductases inhibitors
BR9902049A (pt) Derivados 9a,11b-desidro de 9-oxima-3-ceto-6-o-metileritromicina.
DE69528984D1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
MX9602559A (es) Nuevos derivados de piperidina con actividad antagonista del paf.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0880520

Country of ref document: EP

REN Ceased due to non-payment of the annual fee